Jun 2026 (Q2 FY26) — Aug 4, 2026
UFP Technologies Q2 FY26 — Strong MedTech Growth and Record Adjusted EPS
Read the full callUFP Technologies (UFPT) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
UFP Technologies earnings: last reported Tue, 4 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 174 | +15.1% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 16.1 | +0.1 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 20.9 | +21.4% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
Price
$293.25 +0.54% · +$1.58
Performance +49.9% 1Y
1Y: $195.57 on 17 Oct 2025 → $293.25. High $334.84 (4 Aug 2026), low $185.28 (30 Oct 2025).
- Previous close
- $291.67
- 52-week range
- $185.28 – $334.84
- One year
- +48.66%
Overview
- Symbol
- UFPT
- Sector
- Health Care
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
UFP Technologies earnings calls (UFPT)
Financials
What the filings say
Net profit, year on year: +21% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 145 | 144 | 148 | 151 | 155 | 149 | 154 | 174 |
| Operating profit | 25 | 22 | 23 | 24 | 23 | 22 | 23 | 28 |
| Operating margin | 17.1% | 15.4% | 15.6% | 16.1% | 15.1% | 14.4% | 15.2% | 16.1% |
| Interest | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 |
| Profit before tax | 21 | 19 | 20 | 22 | 21 | 20 | 22 | 26 |
| Tax rate | 22.9% | 14.3% | 15.3% | 20.6% | 22.2% | 10.1% | 19.0% | 21.1% |
| Net profit | 16 | 16 | 17 | 17 | 16 | 18 | 17 | 21 |
| EPS ($ per share) | 2.13 | 2.13 | 2.24 | 2.23 | 2.12 | 2.28 | 2.27 | 2.69 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reserves | 112 | 132 | 145 | 161 | 203 | 248 | 307 | 375 |
| Total liabilities | 49 | 27 | 26 | 140 | 141 | 118 | 286 | 231 |
| Fixed assets | 58 | 57 | 54 | 57 | 58 | 62 | 71 | 79 |
| Total assets | 190 | 189 | 203 | 334 | 378 | 404 | 629 | 655 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 21 | 31 | 25 | 14 | 18 | 41 | 67 | 92 |
| Cash from investing | -82 | -6 | -4 | -101 | 1 | -10 | -210 | -28 |
| Cash from financing | 26 | -25 | -0 | 74 | -26 | -30 | 152 | -58 |
| Net cash flow | -35 | 1 | 20 | -13 | -7 | 1 | 8 | 7 |
| Capital expenditure | -5 | -6 | -4 | -5 | -14 | -10 | -10 | 0 |
| Free cash flow | 16 | 25 | 21 | 9 | 4 | 31 | 57 | 92 |
Insider filings
61 filings between Nov 6, 2025 and Aug 25, 2026.
Open market
decisions to buy or sellPurchases
None
No insider bought shares.
Sales
$13.99M
27 sales by 7 insiders
Compensation
not trading decisions- 21
- Award — granted as compensation
- 5
- Option exercise — converted options into shares
- 7
- Tax withheld — shares kept back by the company to cover tax
Also filed: 1 gift.
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| BAILLY R JEFFREY | — | $9.11M | Aug 10, 2026 |
| KOZIN MARC D | — | $2.13M | Aug 25, 2026 |
| Hudson Symeria | — | $720.2K | Aug 18, 2026 |
| CROTEAU DANIEL C | — | $635.0K | May 12, 2026 |
| FELDMANN CYNTHIA L | — | $611.4K | Aug 13, 2026 |
| Litterio Christopher P. | — | $415.5K | Nov 6, 2025 |
| Holt Jason | — | $370.1K | Aug 6, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Aug 25, 2026 | KOZIN MARC D Director | Sale | 3,650 | $1.11M |
| Aug 25, 2026 | KOZIN MARC D Director | Sale | 3,350 | $1.02M |
| Aug 18, 2026 | Hudson Symeria Director | Sale | 298 | $95.1K |
| Aug 14, 2026 | Hudson Symeria Director | Sale | 1,926 | $625.1K |
| Aug 13, 2026 | Hudson Symeria Director | Option exercise | 493 | $128.6K |
| Aug 13, 2026 | FELDMANN CYNTHIA L Director | Sale | 1,000 | $324.3K |
| Aug 13, 2026 | Hudson Symeria Director | Option exercise | 703 | $118.1K |
| Aug 10, 2026 | BAILLY R JEFFREY Executive Chairman | Sale | 5,771 | $1.82M |
| Aug 10, 2026 | BAILLY R JEFFREY Executive Chairman | Sale | 6,866 | $2.17M |
| Aug 10, 2026 | BAILLY R JEFFREY Executive Chairman | Sale | 374 | $118.7K |
| Aug 7, 2026 | BAILLY R JEFFREY Executive Chairman | Sale | 542 | $170.8K |
| Aug 7, 2026 | BAILLY R JEFFREY Executive Chairman | Sale | 4,471 | $1.42M |
| Aug 6, 2026 | BAILLY R JEFFREY Executive Chairman | Sale | 2,805 | $897.7K |
| Aug 6, 2026 | BAILLY R JEFFREY Executive Chairman | Sale | 7,877 | $2.51M |
| Aug 6, 2026 | Holt Jason Vice President | Sale | 1,100 | $348.7K |
| Jun 12, 2026 | FELDMANN CYNTHIA L Director | Sale | 1,100 | $263.1K |
| Jun 12, 2026 | FELDMANN CYNTHIA L Director | Option exercise | 1,200 | $52.7K |
| Jun 12, 2026 | FELDMANN CYNTHIA L Director | Sale | 100 | $24.0K |
| Jun 5, 2026 | BAILLY R JEFFREY Executive Chairman | Tax withheld | 750 | $167.9K |
| Jun 5, 2026 | BAILLY R JEFFREY Executive Chairman | Award | 1,787 | $0 |
| Jun 4, 2026 | KOZIN MARC D Director | Award | 802 | $0 |
| Jun 4, 2026 | LATAILLE RONALD J Chief Financial Officer | Award | 4,454 | $0 |
| Jun 4, 2026 | Stafford Ryan K SVP Human Resources | Award | 1,448 | $0 |
| Jun 4, 2026 | ROCK MITCHELL President | Award | 2,895 | $0 |
| Jun 4, 2026 | Hassett Joseph Director | Award | 802 | $0 |
| Jun 4, 2026 | Hudson Symeria Director | Award | 802 | $0 |
| Jun 4, 2026 | FELDMANN CYNTHIA L Director | Award | 802 | $0 |
| Jun 4, 2026 | OBERDORF THOMAS Director | Award | 802 | $0 |
| Jun 4, 2026 | CROTEAU DANIEL C Director | Award | 802 | $0 |
| May 12, 2026 | CROTEAU DANIEL C Director | Sale | 2,864 | $635.0K |
| May 8, 2026 | CROTEAU DANIEL C Director | Option exercise | 2,864 | $63.1K |
| Mar 11, 2026 | OBERDORF THOMAS Director | Option exercise | 2,864 | $63.1K |
| Mar 2, 2026 | BAILLY R JEFFREY CEO | Tax withheld | 9,422 | $1.92M |
| Mar 2, 2026 | ROCK MITCHELL President | Tax withheld | 2,513 | $513.4K |
| Mar 2, 2026 | Holt Jason Vice President | Tax withheld | 478 | $97.7K |
| Mar 2, 2026 | Litterio Christopher P. Senior Vice President | Tax withheld | 815 | $166.5K |
| Mar 2, 2026 | LATAILLE RONALD J Chief Financial Officer | Tax withheld | 2,677 | $546.9K |
| Feb 10, 2026 | ROCK MITCHELL President | Award | 2,463 | $0 |
| Feb 10, 2026 | Holt Jason Vice President | Award | 1,121 | $0 |
| Feb 10, 2026 | BAILLY R JEFFREY CEO | Award | 19,061 | $0 |
| Feb 10, 2026 | Litterio Christopher P. Senior Vice President | Award | 1,215 | $0 |
| Feb 10, 2026 | Litterio Christopher P. Senior Vice President | Award | 821 | $0 |
| Feb 10, 2026 | ROCK MITCHELL President | Award | 3,270 | $0 |
| Feb 10, 2026 | BAILLY R JEFFREY CEO | Award | 7,428 | $0 |
| Feb 10, 2026 | LATAILLE RONALD J Chief Financial Officer | Award | 3,115 | $0 |
| Feb 10, 2026 | Holt Jason Vice President | Award | 657 | $0 |
| Feb 10, 2026 | LATAILLE RONALD J Chief Financial Officer | Award | 2,463 | $0 |
| Dec 19, 2025 | BAILLY R JEFFREY President and CEO | Award | 1,744 | $0 |
| Dec 19, 2025 | BAILLY R JEFFREY President and CEO | Tax withheld | 888 | $203.7K |
| Dec 10, 2025 | Holt Jason Vice President | Sale | 100 | $21.4K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for UFP TECHNOLOGIES INC
Free account. Everything above stays public.
Write why you follow UFP TECHNOLOGIES INC and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading